IVIVC Test Systems for DDU and APSD
Two factors have been identified as being critical to improving the clinical relevance of DDU testing and APSD measurement: realistic breathing profiles and realistic throat and nasal models.
HCP6 High Capacity Pump
View ProductCritical Flow Controller TPK 100i
View ProductNext Generation Impactor NGI
View BrochureNGI Induction Port
View BrochureMixing Inlet
View BrochureMouthpiece Adapters
View ProductNGI Cooler™
View BrochureCompressed Air Flow Controller
View BrochureBreathing Simulator BRS 200i
View ProductAlberta Idealised Throat AIT
View ProductAir Compressor for Mixing Inlet
View BrochureReal-Time Breath Profile Verification Chamber
View BrochureDDU of Nebulisers
View SystemAPSD of Nebulisers
View SystemHCP6 High Capacity Pump
View ProductCritical Flow Controller TPK 100i
View ProductNext Generation Impactor NGI
View BrochureNGI Induction Port
View BrochureMixing Inlet
View BrochureMouthpiece Adapters
View ProductNGI Cooler™
View BrochureCompressed Air Flow Controller
View BrochureBreathing Simulator BRS 200i
View ProductAlberta Idealised Throat AIT
View ProductAir Compressor for Mixing Inlet
View BrochureReal-Time Breath Profile Verification Chamber
View BrochureDDU of Nebulisers
View SystemAPSD of Nebulisers
View SystemSystem for Improved In Vitro-In Vivo Correlations (IVIVCs) of Inhaled Drug Products
Play VideoRelated Services
Related News & Resources

Introducing the Copley Impactor Genie™ IG 200i, a two-in-one solution for quicker, more efficient inhaled product testing
25th April 2023; Nottingham, UK: The new Impactor Genie™ IG 200i from Copley Scientific is a cost- and space-efficient semi-automation tool for regulatory and…
Find Out More
Copley Scientific joins the Industries Forum of the Taskforce for Lung Health
23 June 2021; Nottingham, UK: Copley Scientific has joined the Industries Forum of the Taskforce for Lung Health. The Taskforce is a collaboration of over…
Find Out More
Introducing Inhalytix™: a new solution for analysing and managing inhaler test data from Copley
18 March 2021; Nottingham, UK: Inhalytix™ is a completely new software solution from Copley, the global leader in inhaler testing equipment, that brings a…
Find Out More
Copley announces a major upgrade of the world’s ‘go to’ inhaler testing portfolio
01 March 2021, Nottingham, UK: Copley Scientific, the global leaders in inhaler testing equipment, is marking the company’s 75th anniversary with a significant upgrade…
Find Out More
New e-Training service from Copley for pharmaceutical testing
14 January 2021; Nottingham, UK: Copley Scientific is now delivering e-Training, offering customers across the globe remote access to expert tuition on in vitro…
Find Out More
Improving clinical realism: Upgraded IVIVC testing systems from Copley Scientific
29th June 2018; Nottingham, UK: New products from Copley Scientific enhance its offering for improving IVIVCs for orally inhaled and nasal drug products (OINDPs)….
Find Out More
New research demonstrates the ability of the Child Alberta Idealised Throat to deliver better IVIVRs
28 May 2015; Nottingham, UK: New experimental studies using the Child Alberta Idealised Throat (C-AIT) from Copley Scientific confirm that it provides data more…
Find Out More
Copley Scientific introduces improved test set-up for more representative inhaled product testing
5 August 2014; Nottingham, UK: The desire to gain a better understanding of how inhaled products perform in patients has highlighted the importance and…
Find Out More
Introducing the new Alberta Idealized Throats from Copley Scientific – closer IVIVC in inhaled product testing
1 December 2010; Nottingham, UK: The Alberta Idealized Throat is a new product from Copley Scientific designed to improve in vivo/in vitro correlation (IVIVC)…
Find Out More
Q&A: OINDPnews 2022
Reducing Inhaler Testing Variability Through Test Environment Control In this Q&A with OINDPnews, our CEO Mark Copley answers questions about the importance of the…
Find Out More
PMPS Q&A (Samedan): April 2021
Putting Inhalers to the Test Anna Sipitanou has worked for Copley Scientific for four years, expanding her drug discovery and pharma science background. She…
Find Out More
Microbioz India: February 2021
A short Q&A with our CEO, Mark Copley, on inhaled product testing
Find Out More
ONdrugDelivery Article: November 2020
Semi-Automation in Inhaler Testing – Exploring the Potential and Practicalities In this article, João Pereira, Team Leader R&D Analytical Development, and Raquel Borda D’Água,…
Find Out More
Inhalation Article: April 2019
The regulatory landscape for OINDPs – the biggest shake-up in a generation?
Find Out More
ONdrugDelivery Article: December 2018
Variability in cascade impaction: sources, impact and strategies for reduction In this article, Mark Copley, Chief Executive Officer, Copley Scientific, considers cascade impaction as…
Find Out More
Drug Development & Delivery Article: April 2018
Optimizing the Application of In Vitro Test Methods for the Demonstration of Bioequivalence in Orally Inhaled Products
Find Out More
PMPS Article (Samedan): February 2018
Demonstrating Bioequivalence of Orally Inhaled Products Safe and cost-effective treatments for respiratory diseases are facing a growing demand. The demonstration of bioequivalence within locally…
Find Out More
White Paper: February 2018
Optimising the application of in vitro test methods for the demonstration of BE in OIPs
Find Out MoreHave a question? Our friendly and experienced team are here to help.